Hematology/Oncology

Top Story

Johns Hopkins names clinical director of medical oncology

Johns Hopkins names clinical director of medical oncology
February 27, 2017

Benjamin Levy, MD, has been named clinical director of medical oncology and medical director of thoracic oncology for Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital.

Levy will develop a multispecialty program for lung cancer that integrates oncology, pathology, radiation oncology and surgery.

In the Journals Plus

Cardiac events common after radiotherapy in NSCLC

February 27, 2017
AUTHORS: Wang K, Eblan MJ, Deal AM, Lipner M, Zagar TM, Wang Y, Mavroidis P, Lee CB, Jensen BC, Rosenman JG, Socinski MA, Stinchcombe TE, Marks LB.
FDA News

FDA grants fast track designation to ImmunoPulse IL-12 for melanoma

February 27, 2017
The FDA granted fast track designation to ImmunoPulse IL-12 for the treatment of metastatic melanoma that progressed during therapy with pembrolizumab or nivolumab…
In the Journals Plus

Residual cancer burden predicts long-term breast cancer survival

February 27, 2017
A residual cancer burden index provided long-term prognostic data for patients with breast cancer after receiving neoadjuvant chemotherapy alone or with HER-2 targeted…
In the Journals Plus

Toxicity rates high after cetuximab therapy for anal carcinoma

February 26, 2017
The addition of cetuximab to chemoradiotherapy was associated with a lower incidence of locoregional failure in patients with squamous cell carcinoma of the anal canal…
More News Headlines »
CME

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis…
More »
Video
Meeting News

VIDEO: Advances in CAR T cells offer significant potential for patients with leukemia

January 19, 2017
More »
Featured
CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement